S&P 500   3,945.57 (+0.74%)
DOW   32,194.92 (+1.04%)
QQQ   304.88 (-0.16%)
AAPL   157.34 (+1.51%)
MSFT   270.64 (-3.15%)
META   197.47 (+0.95%)
GOOGL   101.19 (-0.42%)
AMZN   97.02 (-1.95%)
TSLA   183.10 (+1.65%)
NVDA   258.05 (+0.31%)
NIO   8.69 (+5.21%)
BABA   80.74 (-1.14%)
AMD   96.15 (-1.73%)
T   18.44 (+1.71%)
F   11.19 (-0.97%)
MU   57.14 (+0.85%)
CGC   1.87 (-6.50%)
GE   89.61 (-0.75%)
DIS   93.72 (+0.56%)
AMC   4.30 (+2.87%)
PFE   40.59 (+1.22%)
PYPL   72.70 (-0.40%)
NFLX   303.72 (+0.07%)
S&P 500   3,945.57 (+0.74%)
DOW   32,194.92 (+1.04%)
QQQ   304.88 (-0.16%)
AAPL   157.34 (+1.51%)
MSFT   270.64 (-3.15%)
META   197.47 (+0.95%)
GOOGL   101.19 (-0.42%)
AMZN   97.02 (-1.95%)
TSLA   183.10 (+1.65%)
NVDA   258.05 (+0.31%)
NIO   8.69 (+5.21%)
BABA   80.74 (-1.14%)
AMD   96.15 (-1.73%)
T   18.44 (+1.71%)
F   11.19 (-0.97%)
MU   57.14 (+0.85%)
CGC   1.87 (-6.50%)
GE   89.61 (-0.75%)
DIS   93.72 (+0.56%)
AMC   4.30 (+2.87%)
PFE   40.59 (+1.22%)
PYPL   72.70 (-0.40%)
NFLX   303.72 (+0.07%)
S&P 500   3,945.57 (+0.74%)
DOW   32,194.92 (+1.04%)
QQQ   304.88 (-0.16%)
AAPL   157.34 (+1.51%)
MSFT   270.64 (-3.15%)
META   197.47 (+0.95%)
GOOGL   101.19 (-0.42%)
AMZN   97.02 (-1.95%)
TSLA   183.10 (+1.65%)
NVDA   258.05 (+0.31%)
NIO   8.69 (+5.21%)
BABA   80.74 (-1.14%)
AMD   96.15 (-1.73%)
T   18.44 (+1.71%)
F   11.19 (-0.97%)
MU   57.14 (+0.85%)
CGC   1.87 (-6.50%)
GE   89.61 (-0.75%)
DIS   93.72 (+0.56%)
AMC   4.30 (+2.87%)
PFE   40.59 (+1.22%)
PYPL   72.70 (-0.40%)
NFLX   303.72 (+0.07%)
S&P 500   3,945.57 (+0.74%)
DOW   32,194.92 (+1.04%)
QQQ   304.88 (-0.16%)
AAPL   157.34 (+1.51%)
MSFT   270.64 (-3.15%)
META   197.47 (+0.95%)
GOOGL   101.19 (-0.42%)
AMZN   97.02 (-1.95%)
TSLA   183.10 (+1.65%)
NVDA   258.05 (+0.31%)
NIO   8.69 (+5.21%)
BABA   80.74 (-1.14%)
AMD   96.15 (-1.73%)
T   18.44 (+1.71%)
F   11.19 (-0.97%)
MU   57.14 (+0.85%)
CGC   1.87 (-6.50%)
GE   89.61 (-0.75%)
DIS   93.72 (+0.56%)
AMC   4.30 (+2.87%)
PFE   40.59 (+1.22%)
PYPL   72.70 (-0.40%)
NFLX   303.72 (+0.07%)
OTCMKTS:XSNX

NovAccess Global - XSNX Stock Forecast, Price & News

$0.24
+0.07 (+39.41%)
(As of 03/17/2023 08:55 PM ET)
Add
Compare
Today's Range
$0.17
▼
$0.24
50-Day Range
$0.14
▼
$0.25
52-Week Range
$0.10
▼
$0.60
Volume
17,100 shs
Average Volume
8,707 shs
Market Capitalization
$4.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

XSNX stock logo

About NovAccess Global (OTCMKTS:XSNX) Stock

NovAccess Global, Inc. is a biopharmaceutical company, which engages in the provision of diagnostics, therapeutics in cancer, and neurological diseases and the development of immunotherapies to treat brain tumor patients. The company was founded on February 25, 1997 and is headquartered in Cuyahoga County, OH.

Receive XSNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovAccess Global and its competitors with MarketBeat's FREE daily newsletter.

XSNX Stock News Headlines

March 15, 2023 | finanznachrichten.de
NovAccess Global Inc.: Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award
March 15, 2023 | finance.yahoo.com
Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award
March 20, 2023 | Stansberry Research (Ad)
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
February 16, 2023 | finanznachrichten.de
NovAccess Global Inc.: NovAccess Global to Present at World Orphan Drug Congress
February 16, 2023 | finance.yahoo.com
NovAccess Global to Present at World Orphan Drug Congress
February 3, 2023 | finanznachrichten.de
NovAccess Global Inc.: NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress
February 3, 2023 | finance.yahoo.com
NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress
January 5, 2023 | finance.yahoo.com
NovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company’s Lead Scientist and President of its StemVax Therapeutics Division
March 20, 2023 | Oxford Club (Ad)
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
November 22, 2022 | finanznachrichten.de
NovAccess Global Inc.: NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate
November 22, 2022 | finance.yahoo.com
NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate
November 10, 2022 | finanznachrichten.de
NovAccess Global Inc.: NovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory Board
November 10, 2022 | finance.yahoo.com
NovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory Board
November 8, 2022 | finance.yahoo.com
NovAccess Global Announces Virtual Annual Shareholders' Meeting
October 26, 2022 | finance.yahoo.com
NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1
October 20, 2022 | finanznachrichten.de
NovAccess Global Inc.: NovAccess Global Announces Fireside Chat with Board Member Perspectives
October 20, 2022 | finance.yahoo.com
NovAccess Global Announces Fireside Chat with Board Member Perspectives
October 1, 2022 | finanznachrichten.de
Darrow Associates, Inc.: NovAccess Global Announces Fireside Chat Series for the Investment Community
September 30, 2022 | seekingalpha.com
XSNX NovAccess Global Inc.
September 30, 2022 | seekingalpha.com
XSNX NovAccess Global Inc.
September 29, 2022 | finance.yahoo.com
NovAccess Global Announces Fireside Chat Series for the Investment Community
September 23, 2022 | finanznachrichten.de
NovAccess Global Inc.: NovAccess Global Announces Effectiveness of Form S-1 Registration Statement
September 22, 2022 | finance.yahoo.com
NovAccess Global Announces Effectiveness of Form S-1 Registration Statement
September 6, 2022 | reuters.com
NovAccess Global Inc
August 10, 2022 | finanznachrichten.de
NovAccess Global Inc.: NovAccess Global Announces Uplisting to OTCQB
August 10, 2022 | finance.yahoo.com
NovAccess Global Announces Uplisting to OTCQB
July 19, 2022 | finance.yahoo.com
CORRECTION: NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1
See More Headlines
Receive XSNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovAccess Global and its competitors with MarketBeat's FREE daily newsletter.

XSNX Company Calendar

Today
3/20/2023
Fiscal Year End
9/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:XSNX
CUSIP
N/A
CIK
1039466
Web
www.xsunx.com
Phone
(213) 642-9268
Fax
949-266-5823
Employees
2
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,720,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-3,684.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.01
Quick Ratio
0.01

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.50) per share
Price / Book
-0.47

Miscellaneous

Outstanding Shares
20,980,000
Free Float
20,674,000
Market Cap
$4.97 million
Optionable
Not Optionable
Beta
1.63

Key Executives

  • Dwain Morris-Irvin
    Chief Executive Officer
  • Neil J. Laird
    Chief Financial Officer

Key Competitors

View All Competitors













XSNX Stock - Frequently Asked Questions

How have XSNX shares performed in 2023?

NovAccess Global's stock was trading at $0.29 on January 1st, 2023. Since then, XSNX stock has decreased by 18.3% and is now trading at $0.2370.
View the best growth stocks for 2023 here.

Are investors shorting NovAccess Global?

NovAccess Global saw a decrease in short interest in the month of February. As of February 28th, there was short interest totaling 3,600 shares, a decrease of 52.6% from the February 13th total of 7,600 shares. Based on an average trading volume of 6,200 shares, the days-to-cover ratio is presently 0.6 days.
View NovAccess Global's Short Interest.

What other stocks do shareholders of NovAccess Global own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NovAccess Global investors own include Co-Diagnostics (CODX), iBio (IBIO), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN), Ascent Solar Technologies (ASTI) and BioRestorative Therapies (BRTX).

What is NovAccess Global's stock symbol?

NovAccess Global trades on the OTCMKTS under the ticker symbol "XSNX."

How do I buy shares of NovAccess Global?

Shares of XSNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NovAccess Global's stock price today?

One share of XSNX stock can currently be purchased for approximately $0.24.

How much money does NovAccess Global make?

NovAccess Global (OTCMKTS:XSNX) has a market capitalization of $4.97 million.

How can I contact NovAccess Global?

NovAccess Global's mailing address is 8834 MAYFIELD RD, CHESTERLAND OH, 44026. The official website for the company is www.xsunx.com. The company can be reached via phone at (213) 642-9268, via email at investors@xsunx.com, or via fax at 949-266-5823.

This page (OTCMKTS:XSNX) was last updated on 3/20/2023 by MarketBeat.com Staff